fbpx 55023-001: Strengthening Rapid Epidemic Response Capacity of Health Systems Project | Asian Development Bank

Mongolia: Strengthening Rapid Epidemic Response Capacity of Health Systems Project

Sovereign (Public) Project | 55023-001 Status: Approved

The coronavirus disease (COVID-19) pandemic is causing significant health, social, and economic impacts on Mongolia. The project will help the country respond to the ongoing outbreak of COVID-19 by providing resources and training support that will help strengthen its capacity for (i) conducting reverse transcription polymerase chain reaction (RT-PCR) tests, (ii) administering COVID-19 vaccines to target populations in compliance with infection prevention and control (IPC) protocols, (iii) ensuring the complete uptake of immunization services by target groups, and (iv) undertaking post-immunization surveillance. The project is closely linked to the Support for COVID-19 Vaccine Delivery in Mongolia under the Asia Pacific Vaccine Access Facility which will provide safe and effective COVID-19 vaccines in Mongolia. The project has strong pro-poor and socially inclusive features.

Project Details

Project Officer
Mamatkulov, Raushanbek East Asia Department Request for information
Country
  • Mongolia
Sector
  • Health
 
Project Name Strengthening Rapid Epidemic Response Capacity of Health Systems Project
Project Number 55023-001
Country Mongolia
Project Status Approved
Project Type / Modality of Assistance Grant
Source of Funding / Amount
Grant 9218-MON: Strengthening Rapid Epidemic Response Capacity of Health Systems in Mongolia
Japan Fund for Poverty Reduction US$ 5.00 million
Strategic Agendas Inclusive economic growth
Regional integration
Drivers of Change Gender Equity and Mainstreaming
Governance and capacity development
Partnerships
Sector / Subsector

Health / Disease control of communicable disease

Gender Equity and Mainstreaming Some gender elements
Description The coronavirus disease (COVID-19) pandemic is causing significant health, social, and economic impacts on Mongolia. The project will help the country respond to the ongoing outbreak of COVID-19 by providing resources and training support that will help strengthen its capacity for (i) conducting reverse transcription polymerase chain reaction (RT-PCR) tests, (ii) administering COVID-19 vaccines to target populations in compliance with infection prevention and control (IPC) protocols, (iii) ensuring the complete uptake of immunization services by target groups, and (iv) undertaking post-immunization surveillance. The project is closely linked to the Support for COVID-19 Vaccine Delivery in Mongolia under the Asia Pacific Vaccine Access Facility which will provide safe and effective COVID-19 vaccines in Mongolia. The project has strong pro-poor and socially inclusive features.
Project Rationale and Linkage to Country/Regional Strategy

On 30 January 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern. On 11 March 2020, WHO declared the COVID-19 a pandemic. By 3 June 2021, nearly 171.6 million people had been diagnosed with COVID-19, with more than 3.7 million deaths, globally. The first case of community transmission in Mongolia was reported on 10 November 2020, and since then several clusters of local transmission have emerged in Ulaanbaatar and in six provinces. The Government of Mongolia initiated stringent measures to prevent the spread of COVID-19, including international and national travel restrictions; the closure of schools and kindergartens and all non-essential business, public awareness campaigns, restrictions on public gatherings, meetings, and celebrations; and preparation of hospitals to manage emergencies in the event of a surge of cases. The government has implemented three rounds of strict lockdowns from November 2020 to end of May 2021. As of 3 June 2021, there have been 60,372 cases of COVID-19 with 286 deaths recorded in the country (footnote 3). The risk of continued community spread of COVID-19 remains substantial. Of these, some 522,428 people are at high risk (i.e., frontline medical workers, emergency management staff, police and border military personnel, state inspectors, and the elderly).

The COVID-19 crisis is more severe and prolonged than the initial expectations in early 2020. In 2020, the economy of Mongolia shrank significantly by 5.3% in 12 months because of the COVID-19 crisis, a drop of 10.5 percentage points compared with 2019. The official job losses reached 63,900 or 5.4% of total employment, and unemployment rate increased by 1.0 percentage point to 7.6% in the second half of 2020. Except agriculture, all sectors including construction, services, trade, transportation, and other industries shrank, affected by negative spillovers of the pandemic. Overall budget deficit increased significantly to 9.6% of the gross domestic product (GDP) in 2020 because of revenue shortfalls, fiscal response measures against the COVID-19, and contraction in GDP. This led to a temporary increase in public debt-to-GDP ratio, including the central bank's external liabilities, by 14.1 percentage points to 92.4% by end of 2020. Public health concerns have been elevated since the first community transmission of COVID-19 in November 2020.

To effectively pursue COVID-19 containment measures, Mongolia needs to expand its network of molecular biology laboratories to increase capacity for RT-PCR testing. The increased testing capacity will help the government expand screening and surveillance of the population and thereby reduce COVID-19 cases. At the same time, the country needs to rapidly prepare for COVID-19 vaccination to bring the epidemic under control and allow the country to safely reopen borders, enterprises, and schools. The efficient and safe distribution and administration of the vaccine requires capacity development and resource support for social mobilization and community engagement, compliance with IPC protocols at all immunization units, registration, recording and reporting, and post-vaccine surveillance.

Impact Morbidity and mortality of COVID-19 reduced
Project Outcome
Description of Outcome COVID-19 detection and containment strengthened
Progress Toward Outcome
Implementation Progress
Description of Project Outputs

Goods and services for COVID-19 testing and immunization procured

Capacity for efficient and safe vaccination of COVID-19 improved

Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide, Ulaanbaatar
Safeguard Categories
Environment C
Involuntary Resettlement C
Indigenous Peoples C
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation
Business Opportunities
Consulting Services Individual consultant selection - 5 contracts
Procurement Request for quotations - Multiple contracts
Responsible ADB Officer Mamatkulov, Raushanbek
Responsible ADB Department East Asia Department
Responsible ADB Division Urban and Social Sectors Division, EARD
Executing Agencies
Ministry of Health (formerly Ministry of Health and Sports)
[email protected]
1st Floor, Government Building VIII
Olympic Street 2, Ulaanbaatar
Mongolia
Ministry of Health (formerly Ministry of Health and Sports)
1st Floor, Government Building VIII
Olympic Street 2, Ulaanbaatar
Mongolia
Timetable
Concept Clearance -
Fact Finding 02 Mar 2021 to 04 Mar 2021
MRM -
Approval 29 Jun 2021
Last Review Mission -
Last PDS Update 30 Jun 2021

Grant 9218-MON

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
29 Jun 2021 - - 31 Dec 2024 - -
Financing Plan Grant Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 5.36 Cumulative Contract Awards
ADB 0.00 29 Jun 2021 0.00 0.00 0%
Counterpart 0.36 Cumulative Disbursements
Cofinancing 5.00 29 Jun 2021 0.00 0.00 0%

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.

Safeguard Documents See also: Safeguards

Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.

Evaluation Documents See also: Independent Evaluation

None currently available.

Related Publications

None currently available.


The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

No tenders for this project were found.

Contracts Awarded

No contracts awarded for this project were found